Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TACT method for non-inferiority testing in active controlled trials.

Sue-Jane Wang1, H M James Hung

  • 1Division of Biometrics II, OB/OPaSS/CDER/FDA, Rockville, MD 20857, USA. wangs@cder.fda.gov

Statistics in Medicine
|January 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-β PET Drugs for Selection of Patients for Amyloid-β-Directed Therapies and Other Labeling Updates.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures.

Radiation research·2024
Same author

Quantitative Brain Amyloid PET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2024
Same author

The impact of misclassification errors on the performance of biomarkers based on next-generation sequencing, a simulation study.

Journal of biopharmaceutical statistics·2023
Same author

US FDA public meeting: identification of concepts and terminology for multicomponent biomarkers.

Biomarkers in medicine·2023
Same author

Bayesian Sample Size Planning Tool for Phase I Dose-Finding Trials.

JCO precision oncology·2022

A new statistical method, Two-stage Active Control Testing (TACT), offers a compromise for active controlled trials without placebo. TACT provides valid alpha error rates and maintains power, avoiding uninterpretable non-inferiority tests.

Area of Science:

  • Biostatistics
  • Clinical Trial Design

Background:

  • Active controlled trials without placebo arms present unique statistical challenges for non-inferiority testing.
  • Existing methods like synthesis and confidence interval approaches have limitations regarding alpha error control and power.

Purpose of the Study:

  • To develop a novel statistical method, Two-stage Active Control Testing (TACT), as a compromise between existing approaches.
  • To ensure valid alpha error rates and maintain statistical power in active controlled trials.

Main Methods:

  • Development of the Two-stage Active Control Testing (TACT) method.
  • Evaluation of TACT's performance under various conditions, comparing it to synthesis and confidence interval methods.

Main Results:

Related Experiment Videos

  • The TACT method provides a viable compromise, avoiding uninterpretable non-inferiority tests.
  • TACT demonstrates a valid alpha error rate and power comparable to the synthesis method when the constancy condition holds.
  • TACT is more powerful than the confidence interval method for assessing new treatment efficacy and non-inferiority to active controls.

Conclusions:

  • The TACT method offers a robust and powerful statistical approach for active controlled trials.
  • TACT enhances the reliability of non-inferiority testing and efficacy evaluation in the absence of a placebo arm.